Esperion Therapeutics
ESPR
#8331
Rank
C$0.23 B
Marketcap
$1.18
Share price
-10.32%
Change (1 day)
-55.25%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$3.82

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.90. In 2022 the company made an earnings per share (EPS) of -$4.91 an increase over its 2021 EPS that were of -$13.23.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.82-22.34%
2022-$4.91-62.87%
2021-$13.2380.38%
2020-$7.3450.14%
2019-$4.89-53.18%
2018-$10.447.41%
2017-$9.72110.81%
2016-$4.6147.35%
2015-$3.130.89%
2014-$3.1028.84%
2013-$2.41-89.3%
2012-$22.50
2002-$9.488.89%
2001-$8.70-83.77%
2000-$53.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$14.18 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.08-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.57-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.72-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.89-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.94-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA